Role of fecal calprotectin as a hypoxic intestinal damage biomarker in COVID-19 patients
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of fecal calprotectin as a hypoxic intestinal damage biomarker in COVID-19 patients
Authors
Keywords
-
Journal
Gut Pathogens
Volume 14, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-08-09
DOI
10.1186/s13099-022-00507-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potential intestinal infection and faecal–oral transmission of SARS-CoV-2
- (2021) Meng Guo et al. Nature Reviews Gastroenterology & Hepatology
- Calprotectin, an Emerging Biomarker of Interest in COVID-19: A Systematic Review and Meta-Analysis
- (2021) Raphael Udeh et al. Journal of Clinical Medicine
- PaO2/FiO2 and IL-6 are risk factors of mortality for intensive care COVID-19 patients
- (2021) Yanli Gu et al. Scientific Reports
- High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study
- (2021) Verena Zerbato et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19
- (2021) Graham J. Britton et al. Scientific Reports
- Elevated fecal and serum calprotectin in COVID-19 are not consistent with gastrointestinal symptoms
- (2021) Hajar Shokri-Afra et al. Scientific Reports
- Role of SatO2, PaO2/FiO2 Ratio and PaO2 to Predict Adverse Outcome in COVID-19: A Retrospective, Cohort Study
- (2021) Stefano Sartini et al. International Journal of Environmental Research and Public Health
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China
- (2020) Lei Pan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- COVID-19 and the Digestive System
- (2020) Chunxiang Ma et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Clinical Insights into the Gastrointestinal Manifestations of COVID-19
- (2020) Jonathan Kopel et al. DIGESTIVE DISEASES AND SCIENCES
- The utility of fecal calprotectin in the era of COVID-19 pandemic
- (2020) Sheena Mago et al. GASTROENTEROLOGY
- Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples from the Hong Kong Cohort and Systematic Review and Meta-analysis
- (2020) Ka Shing Cheung et al. GASTROENTEROLOGY
- Faecal calprotectin indicates intestinal inflammation in COVID-19
- (2020) Maria Effenberger et al. GUT
- Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process
- (2020) Hao Zhang et al. GUT
- Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms
- (2020) Xi Jin et al. GUT
- Association of inflammatory markers with the severity of COVID-19: a meta-analysis
- (2020) Furong Zeng et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
- (2020) Waradon Sungnak et al. NATURE MEDICINE
- The mechanism and treatment of gastrointestinal symptoms in patients with COVID-19
- (2020) Qing Ye et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications
- (2020) Franco Scaldaferri et al. INFLAMMATORY BOWEL DISEASES
- Oxygen battle in the gut: Hypoxia and hypoxia-inducible factors in metabolic and inflammatory responses in the intestine
- (2020) Rashi Singhal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Prevalence and Mortality of COVID-19 Patients With Gastrointestinal Symptoms: A Systematic Review and Meta-analysis
- (2020) Raseen Tariq et al. MAYO CLINIC PROCEEDINGS
- Potential Causes and Consequences of Gastrointestinal Disorders during a SARS-CoV-2 Infection
- (2020) François Trottein et al. Cell Reports
- Enteric involvement in hospitalised patients with COVID-19 outside Wuhan
- (2020) Yunle Wan et al. Lancet Gastroenterology & Hepatology
- D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study
- (2020) Yumeng Yao et al. Journal of Intensive Care
- Fecal calprotectin levels in COVID-19: Lessons from a systematic review on its use in inflammatory bowel disease during the pandemic
- (2020) Anuraag Jena et al. DIGESTIVE AND LIVER DISEASE
- Gastrointestinal implications in COVID-19
- (2020) Dushyant Singh Dahiya et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Hypoxia and Mucosal Inflammation
- (2016) Sean P. Colgan et al. Annual Review of Pathology-Mechanisms of Disease
- The use of fecal calprotectin as a biomarker in gastrointestinal disease
- (2013) Emanuel Burri et al. Expert Review of Gastroenterology & Hepatology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More